Daniel E. Geffken
CIK 1314756 · Interim CFO · last filed 2024-05-20
Daniel E. Geffken is an Interim CFO who has filed 14 SEC Form 4 insider transactions across 7 companies since 2019. The most recent filing, for CALC, was dated May 20, 2024. Across all open-market trades the lifetime net is +$51.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $676.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$676.0K
7
14
$51.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | Interim CFO | — | $0.87 | — | $0 | 2 | 2024-05-20 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Chief Financial Officer | 10,002 | $0.05 | $501 | $0 | 1 | 2024-02-16 |
| PMN | Chief Financial Officer | — | $10.35 | — | $0 | 1 | 2023-10-30 |
| WINT | Director | 2,175 | $0.01 | $31 | $15.0K | 6 | 2023-08-29 |
| ELOX | INTERIM CFO | 50,000 | $13.52 | $676.0K | $36.0K | 2 | 2021-12-01 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | Chief Financial Officer | — | $10.37 | — | $0 | 1 | 2021-10-12 |
| LWACU | Chief Financial Officer | — | $10.30 | — | $0 | 1 | 2021-01-14 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-20 | CALC | Grant (A) | — | $0 | EDGAR |
| 2024-02-16 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Other (J) | +10,002 | $0 | EDGAR |
| 2023-10-30 | PMN | Grant (A) | — | $0 | EDGAR |
| 2023-08-29 | WINT | Grant (A) | +2,033 | $0 | EDGAR |
| 2023-05-03 | CALC | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | WINT | Grant (A) | +5,000 | $0 | EDGAR |
| 2021-12-01 | ELOX | Buy (P) | +50,000 | $36.0K | EDGAR |
| 2021-10-12 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | Other (J) | — | $0 | EDGAR |
| 2021-06-17 | WINT | Grant (A) | — | $0 | EDGAR |
| 2021-04-22 | ELOX | Grant (A) | — | $0 | EDGAR |